An efficient and safe herpes simplex virus type 1 amplicon vector for transcriptionally targeted therapy of human hepatocellular carcinomas. (Q40147062)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17426711%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

title

An efficient and safe herpes simplex virus type 1 amplicon vector for transcriptionally targeted therapy of human hepatocellular carcinomas (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17426711%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

0 references

1 reference

Herpes simplex virus type 1

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17426711%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Paula Y P Lam

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17426711%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Kian Chuan Sia

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17426711%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Jenn H Khong

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17426711%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Bart De Geest

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17426711%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Kar S Lim

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17426711%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Grace Y Wang

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17426711%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

L V Miao

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17426711%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

H Huynh

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17426711%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Kam M Hui

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17426711%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

10 April 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17426711%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17426711%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17426711%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17426711%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

1129-1136

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17426711%20AND%20SRC:MED&resulttype=core&format=json

CDF-1, a novel E2F-unrelated factor, interacts with cell cycle-regulated repressor elements in multiple promoters.

29 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300165

7 January 2021

A dual specificity promoter system combining cell cycle-regulated and tissue-specific transcriptional control

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300165

7 January 2021

Rapid production of interleukin-2-secreting tumor cells by herpes simplex virus-mediated gene transfer: implications for autologous vaccine production

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300165

7 January 2021

Neoadjuvant Interleukin-12 Immunogene Therapy Protects Against Cancer Recurrence After Liver Resection in an Animal Model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300165

7 January 2021

Efficacy of multiagent herpes simplex virus amplicon-mediated immunotherapy as adjuvant treatment for experimental hepatic cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300165

7 January 2021

Gene transfer into hepatocytes mediated by herpes simplex virus-Epstein-Barr virus hybrid amplicons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300165

7 January 2021

Glioma-specific and cell cycle-regulated herpes simplex virus type 1 amplicon viral vector.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300165

7 January 2021

Targeting proliferating tumor cells via the transcriptional control of therapeutic genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300165

7 January 2021

Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300165

7 January 2021

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300165

7 January 2021

Xenografts of human hepatocellular carcinoma: a useful model for testing drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300165

7 January 2021

Mechanisms of Human Hepatocarcinogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300165

7 January 2021

Gene therapy: designer promoters for tumour targeting

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300165

7 January 2021

Promoters and control elements: designing expression cassettes for gene therapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300165

7 January 2021

In vitro and in vivo hepatoma cell-specific expression of a gene transferred with an adenoviral vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300165

7 January 2021

Prolonged liver-specific transgene expression by a non-primate lentiviral vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300165

7 January 2021

Gene transfer to hepatocellular carcinoma: transduction efficacy and transgene expression kinetics by using retroviral and lentiviral vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300165

7 January 2021

Strain-specific rate of shutdown of CMV enhancer activity in murine liver confirmed by use of persistent [E1(-), E2b(-)] adenoviral vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300165

7 January 2021

Effect of promoters and enhancers on expression, transgene DNA persistence, and hepatotoxicity after adenoviral gene transfer of human apolipoprotein A-I

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300165

7 January 2021

Herpes simplex virus amplicon delivery of a hypoxia-inducible angiogenic inhibitor blocks capillary formation in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300165

7 January 2021

Increasing the size of rAAV-mediated expression cassettes in vivo by intermolecular joining of two complementary vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300165

7 January 2021

Gene therapy progress and prospects--vectorology: design and production of expression cassettes in AAV vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300165

7 January 2021

Delivery of large genomic DNA inserts >100 kb using HSV-1 amplicons.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300165

7 January 2021

An infectious transfer and expression system for genomic DNA loci in human and mouse cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300165

7 January 2021

Hepatoma-specific antitumor activity of an albumin enhancer/promoter regulated herpes simplex virus in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300165

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.MT.6300165

1 reference

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.MT.6300165

1 reference

7 January 2021

Evidence that the herpes simplex virus immediate early protein ICP27 acts post-transcriptionally during infection to regulate gene expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300165

7 January 2021

Persistent hepatic expression of human apo A-I after transfer with a helper-virus independent adenoviral vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300165

7 January 2021

Sustained expression of human apolipoprotein A-I after adenoviral gene transfer in C57BL/6 mice: role of apolipoprotein A-I promoter, apolipoprotein A-I introns, and human apolipoprotein E enhancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300165

7 January 2021

Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300165

7 January 2021

Optimal purification method for Herpes-based viral vectors that confers minimal cytotoxicity for systemic route of vector administration.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300165

7 January 2021

Identifiers

DOI

10.1038/SJ.MT.6300165

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17426711%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17426711%20AND%20SRC:MED&resulttype=core&format=json